Journal Article

Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

René J. Boosman; Merel Jebbink; Wouter B. Veldhuis; Stefanie L. Groenland; Bianca A. M. H. van Veggel; Pim Moeskops; Adrianus J. de Langen; Jos H. Beijnen; Egbert F. Smit; Alwin D. R. Huitema; Neeltje Steeghs

Pharmaceutical Research · Vol. 39, Issue 10 · pp. 2507-2514 · 2022

View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

Journal	Pharmaceutical Research
Publisher	Springer
Publication Date	2022-10-01
Publication Year	2022
Volume	39
Issue	10
Pages	2507-2514
Document Type	Journal Article
Print ISSN	0724-8741
eISSN	1573-904X
DOI	10.1007/s11095-022-03355-2

Access Information

NARA Access Coverage	1984-01-01~Current
Journal Homepage	https://www.springer.com/journal/11095
Publisher Page	Open Publisher Page

Full-text access depends on NARA's subscribed coverage and institutional access.